PAR — Par Drugs and Chemicals Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	751	957	956	1,010	1,037
Cost of Revenue
Gross Profit	463	293	368	332	603
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	621	808	763	851	902
Operating Profit	130	150	194	159	134
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	127	151	195	179	173
Provision for Income Taxes
Net Income After Taxes	92.1	113	145	134	131
Net Income Before Extraordinary Items
Net Income	92.1	113	145	134	131
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	92.1	113	145	134	131
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.49	9.12	11.8	10.9	10.7
Dividends per Share